OneStat.com Web Analytics

About Us

Commitment to Safety

At Insmed, the safety and efficacy of our therapies is our #1 priority.

In keeping with this commitment, Insmed's clinical staff has a broad range of experience from throughout the industry and other laboratory environments.

Insmed's 50,000 square foot, state-of-the-art development and manufacturing facility, ITP, is FDA-inspected and received approval for current Good Manufacturing Practices (cGMP) protein manufacturing.

Press Releases

    • May. 8, 2008
      /C O R R E C T I O N -- Insmed Inc./ Read More
    • May. 8, 2008
      Insmed Announces First Quarter 2008 Financial Results Read More
  • Insmed Stock Price